Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.
Hashimoto M, Kuroda S, Kanaya N, Kadowaki D, Yoshida Y, Sakamoto M, Hamada Y, Sugimoto R, Yagi C, Ohtani T, Kumon K, Kakiuchi Y, Yasui K, Kikuchi S, Yoshida R, Tazawa H, Kagawa S, Yagi T, Urata Y, Fujiwara T.
Hashimoto M, et al. Among authors: hamada y.
Br J Cancer. 2024 Apr;130(7):1187-1195. doi: 10.1038/s41416-024-02583-0. Epub 2024 Feb 5.
Br J Cancer. 2024.
PMID: 38316993
Free PMC article.